Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases
- PMID: 15385542
- DOI: 10.1074/jbc.C400260200
Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases
Abstract
Amyloid fibrillization is multistep process involving soluble oligomeric intermediates, including spherical oligomers and protofibrils. Amyloid oligomers have a common, generic structure, and they are intrinsically toxic to cells, even when formed from non-disease related proteins, which implies they also share a common mechanism of pathogenesis and toxicity. Here we report that soluble oligomers from several types of amyloids specifically increase lipid bilayer conductance regardless of the sequence, while fibrils and soluble low molecular weight species have no effect. The increase in membrane conductance occurs without any evidence of discrete channel or pore formation or ion selectivity. The conductance is dependent on the concentration of oligomers and can be reversed by anti-oligomer antibody. These results indicate that soluble oligomers from many types of amyloidogenic proteins and peptides increase membrane conductance in a conformation-specific fashion and suggest that this may represent the common primary mechanism of pathogenesis in amyloid-related degenerative diseases.
Similar articles
-
Annular protofibrils are a structurally and functionally distinct type of amyloid oligomer.J Biol Chem. 2009 Feb 13;284(7):4230-7. doi: 10.1074/jbc.M808591200. Epub 2008 Dec 18. J Biol Chem. 2009. PMID: 19098006 Free PMC article.
-
Common mechanisms of amyloid oligomer pathogenesis in degenerative disease.Neurobiol Aging. 2006 Apr;27(4):570-5. doi: 10.1016/j.neurobiolaging.2005.04.017. Epub 2006 Feb 14. Neurobiol Aging. 2006. PMID: 16481071 Review.
-
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis.Science. 2003 Apr 18;300(5618):486-9. doi: 10.1126/science.1079469. Science. 2003. PMID: 12702875
-
Conformation-dependent anti-amyloid oligomer antibodies.Methods Enzymol. 2006;413:326-44. doi: 10.1016/S0076-6879(06)13017-7. Methods Enzymol. 2006. PMID: 17046404
-
Do amyloid oligomers act as traps for misfolded proteins? A hypothesis.Amyloid. 2008 Sep;15(3):160-5. doi: 10.1080/13506120802193746. Amyloid. 2008. PMID: 18925454 Free PMC article. Review.
Cited by
-
Alzheimer's disease: which type of amyloid-preventing drug agents to employ?Phys Chem Chem Phys. 2013 Jun 21;15(23):8868-77. doi: 10.1039/c3cp00017f. Epub 2013 Feb 28. Phys Chem Chem Phys. 2013. PMID: 23450150 Free PMC article. Review.
-
Interaction of tau protein with model lipid membranes induces tau structural compaction and membrane disruption.Biochemistry. 2012 Mar 27;51(12):2539-50. doi: 10.1021/bi201857v. Epub 2012 Mar 14. Biochemistry. 2012. PMID: 22401494 Free PMC article.
-
Role of glycosaminoglycan sulfation in the formation of immunoglobulin light chain amyloid oligomers and fibrils.J Biol Chem. 2010 Nov 26;285(48):37672-82. doi: 10.1074/jbc.M110.149575. Epub 2010 Sep 24. J Biol Chem. 2010. PMID: 20870723 Free PMC article.
-
Inducible proteopathies.Trends Neurosci. 2006 Aug;29(8):438-43. doi: 10.1016/j.tins.2006.06.010. Epub 2006 Jun 27. Trends Neurosci. 2006. PMID: 16806508 Free PMC article. Review.
-
Coniferaldehyde attenuates Alzheimer's pathology via activation of Nrf2 and its targets.Theranostics. 2020 Jan 1;10(1):179-200. doi: 10.7150/thno.36722. eCollection 2020. Theranostics. 2020. PMID: 31903114 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical